Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
J Tissue Eng Regen Med ; 10(12): 1021-1032, 2016 12.
Article in English | MEDLINE | ID: mdl-24700552

ABSTRACT

Although bone marrow stromal cells (BMSCs) appear promising for cartilage repair, current clinical results are suboptimal and the success of BMSC-based therapies relies on a number of methodological improvements, among which is better understanding and control of their differentiation pathways. We investigated here the role of the cellular environment (paracrine vs juxtacrine signalling) in the chondrogenic differentiation of BMSCs. Bovine BMSCs were encapsulated in alginate beads, as dispersed cells or as small micro-aggregates, to create different paracrine and juxtacrine signalling conditions. BMSCs were then cultured for 21 days with TGFß3 added for 0, 7 or 21 days. Chondrogenic differentiation was assessed at the gene (type II and X collagens, aggrecan, TGFß, sp7) and matrix (biochemical assays and histology) levels. The results showed that micro-aggregates had no beneficial effects over dispersed cells: matrix production was similar, whereas chondrogenic marker gene expression was lower for the micro-aggregates, under all TGFß conditions tested. This weakened chondrogenic differentiation might be explained by a different cytoskeleton organization at day 0 in the micro-aggregates. Copyright © 2014 John Wiley & Sons, Ltd.


Subject(s)
Bone Marrow Cells/metabolism , Cellular Microenvironment , Chondrogenesis , Animals , Antigens, Differentiation/biosynthesis , Bone Marrow Cells/cytology , Cattle , Cell Aggregation , Cell Differentiation , Cells, Cultured , Gene Expression Regulation , Stromal Cells/cytology , Stromal Cells/metabolism
2.
Eur Cell Mater ; 28: 68-80; discussion 80-1, 2014 Jul 25.
Article in English | MEDLINE | ID: mdl-25059223

ABSTRACT

Recent studies suggest that notochordal cells (NCs) might be involved in intervertebral disc homeostasis, a role exploitable to counteract matrix degradation as observed during degeneration. This study aimed to evaluate the potential of NCs to promote matrix production by nucleus pulposus cells (NPCs) and to compare it to the currently proposed addition of bone marrow stromal cells (BMSCs). Using alginate beads, bovine NPCs were exposed for 28 d to porcine NC conditioned medium (NCCM); direct co-culture with porcine NCs or bovine BMSCs; or the combination of BMSCs and NCCM. Effects on cell proliferation, disc matrix production (proteoglycans, collagens) and disc matrix protein expression (aggrecan, collagen 1 and 2, SOX9) were determined and compared to TGFß stimulation. NCCM strongly promoted NPC proliferation (x 2.2) and matrix production (x 3.9) to levels similar to that with TGFß, whereas the direct addition of NCs had no effect. Co-culture of NPCs and BMSCs led to proteoglycan synthesis similar to NPCs alone, which was slightly improved by NCCM (x 1.5). Histological analysis confirmed biochemical data. Gene expression of analysed proteins remained stable for all groups and unaffected by medium conditions. NCs could substantially stimulate NPCs through factors secreted into conditioned medium and in levels similar to the addition of BMSCs. This study showed that molecular agents secreted by NCs constitute a promising alternative to the proposed "standard" injection of BMSCs for disc repair: their effects are similar, do not require the injection of a large number of cells and can be further amplified when the factors are identified.


Subject(s)
Chondrogenesis , Intervertebral Disc/physiology , Mesenchymal Stem Cell Transplantation , Notochord/cytology , Regeneration , Animals , Cattle , Cells, Cultured , Extracellular Matrix Proteins/genetics , Extracellular Matrix Proteins/metabolism , Humans , Intervertebral Disc/metabolism , Notochord/metabolism
3.
Eur Cell Mater ; 24: 18-28, 2012 Jul 09.
Article in English | MEDLINE | ID: mdl-22777950

ABSTRACT

Transplantation of mesenchymal stem cells (MSCs) with electrotransferred bone morphogenetic protein-2 (BMP-2) transgene is an attractive therapeutic modality for the treatment of large bone defects: it provides both stem cells with the ability to form bone and an effective bone inducer while avoiding viral gene transfer. The objective of the present study was to determine the influence of the promoter driving the human BMP-2 gene on the level and duration of BMP-2 expression after transgene electrotransfer into rat MSCs. Cytomegalovirus, elongation factor-1α, glyceraldehyde 3-phosphate dehydrogenase, and beta-actin promoters resulted in a BMP-2 secretion rate increase of 11-, 78-, 66- and 36-fold over respective controls, respectively. In contrast, the osteocalcin promoter had predictable weak activity in undifferentiated MSCs but induced the strongest BMP-2 secretion rates in osteoblastically-differentiated MSCs. Regardless of the promoter driving the transgene, a plateau of maximal BMP-2 secretion persisted for at least 21 d after the hBMP-2 gene electrotransfer. The present study demonstrates the feasibility of gene electrotransfer for efficient BMP-2 transgene delivery into MSCs and for a three-week sustained BMP-2 expression. It also provides the first in vitro evidence for a safe alternative to viral methods that permit efficient BMP-2 gene delivery and expression in MSCs but raise safety concerns that are critical when considering clinical applications.


Subject(s)
Bone Morphogenetic Protein 2/genetics , Gene Expression , Lac Operon , Osteocalcin/genetics , Animals , Bone Morphogenetic Protein 2/metabolism , Bone and Bones/cytology , Bone and Bones/physiology , Cell Differentiation , Cells, Cultured , Electroporation , Gene Transfer Techniques , Humans , Male , Mesenchymal Stem Cells , Mice , Osteocalcin/metabolism , Plasmids , Promoter Regions, Genetic , Rats , Rats, Inbred Lew , Time Factors , Transgenes
4.
J Biomech ; 43(5): 807-17, 2010 Mar 22.
Article in English | MEDLINE | ID: mdl-19962149

ABSTRACT

Because bone marrow-derived stromal cells (BMSCs) are able to generate many cell types, they are envisioned as source of regenerative cells to repair numerous tissues, including bone, cartilage, and ligaments. Success of BMSC-based therapies, however, relies on a number of methodological improvements, among which better understanding and control of the BMSC differentiation pathways. Since many years, the biochemical environment is known to govern BMSC differentiation, but more recent evidences show that the biomechanical environment is also directing cell functions. Using in vitro systems that aim to reproduce selected components of the in vivo mechanical environment, it was demonstrated that mechanical loadings can affect BMSC proliferation and improve the osteogenic, chondrogenic, or myogenic phenotype of BMSCs. These effects, however, seem to be modulated by parameters other than mechanics, such as substrate nature or soluble biochemical environment. This paper reviews and discusses recent experimental data showing that despite some knowledge limitation, mechanical stimulation already constitutes an additional and efficient tool to drive BMSC differentiation.


Subject(s)
Bone Marrow Cells/cytology , Bone Marrow Cells/physiology , Mechanotransduction, Cellular/physiology , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/physiology , Physical Stimulation/methods , Tissue Engineering/methods , Animals , Cell Culture Techniques/methods , Cell Differentiation , Humans , Osteogenesis/physiology
5.
Gene Ther ; 15(7): 537-44, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18256695

ABSTRACT

Gene electrotransfer is an efficient and reproducible nonviral gene transfer technique useful for the nonpermanent expression of therapeutic transgenes. The present study established optimal conditions for the electrotransfer of reporter genes into mesenchymal stem cells (MSCs) isolated from rat bone marrow by their selective adherence to tissue-culture plasticware. The electrotransfer of the lacZ reporter gene was optimized by adjusting the pulse electric field intensity, electric pulse type, electropulsation buffer conductivity and electroporation temperature. LacZ electrotransfection into MSCs was optimal at 1500 V cm(-1) with pre-incubation in Spinner's minimum essential medium buffer at 22 degrees C. Under these conditions beta-galactosidase expression was achieved in 29+/-3% of adherent cells 48 h post transfection. The kinetics of beta-galactosidase activity revealed maintenance of beta-galactosidase production for at least 10 days. Moreover, electroporation did not affect the MSC potential for multidifferentiation; electroporated MSCs differentiated into osteoblastic, adipogenic and chondrogenic lineages to the same extent as cells that were not exposed to electric pulses. Thus, this study demonstrates the feasibility of efficient transgene electrotransfer into MSCs while preserving cell viability and multipotency.


Subject(s)
Electroporation/methods , Genetic Therapy/methods , Mesenchymal Stem Cells/metabolism , Animals , Cell Culture Techniques , Cell Differentiation , Cells, Cultured , Gene Expression , Lac Operon , Male , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/cytology , Rats , Rats, Inbred Lew , Temperature , Time Factors , Transfection/methods , Transgenes , beta-Galactosidase/genetics
6.
Tissue Eng ; 11(5-6): 814-24, 2005.
Article in English | MEDLINE | ID: mdl-15998221

ABSTRACT

Large bone defects are still a challenge to orthopedic surgeons. In this study, a massive bone defect with a clinically relevant volume was efficiently reconstructed by transplanting an engineered bone in which mesenchymal stem cells (MSCs) expanded in autologous serum (AS) were combined with a porous scaffold. In the first step, we established that the way in which the MSCs are distributed over the scaffold affects the ultimate bone-forming ability of the transplant: constructs consisting of a natural coral scaffold and a pseudo-periosteal layer of MSCs surrounding the implant (coral-MSC3D) formed significantly more bone than constructs in which the MSCs were distributed throughout the implant (p = 0.01). However, bone healing occurred in only one sheep, owing to the high resorption rate of natural coral scaffold. To overcome this problem, constructs in which MSCs were combined with a porous coralline-based hydroxyapatite (CHA) scaffold having the same architecture as natural coral but a lower resorption rate were prepared. After their implantation, these constructs were found to have the same osteogenic potential as autologous bone grafts in terms of the amount of newly formed bone present at 4 months (p = 0.89) and to have been completely replaced by newly formed, structurally competent bone within 14 months. Nevertheless, although the rate of bone healing was strikingly improved when CHA-MSC3D constructs were used (five of seven animals healed) as compared with the coral-MSC3D construct (one of seven healed), it was still less satisfactory than that obtained with autografts (five of five healed).


Subject(s)
Bone Substitutes , Metatarsal Bones , Tissue Engineering , Animals , Anthozoa , Bone Regeneration/physiology , Durapatite , Mesenchymal Stem Cells , Metatarsal Bones/surgery , Prostheses and Implants , Sheep
7.
Pathol Biol (Paris) ; 53(3): 142-8, 2005 Apr.
Article in French | MEDLINE | ID: mdl-15781372

ABSTRACT

Stem cell therapy of skeletal tissues involves the transplantation of stem cells to the tissues that have been damaged by injury or disease. Although these cells can be derived from embryos, the preferred source of skeletal stem cells is the bone marrow as it contains adult stem cells that can be easily driven towards a bone phenotype. More recently, cells with similar potentialities have also been derived from adipose tissue, muscle, or blood. A biomaterial (ceramics or polymers) is often required as a scaffold to promote cell adhesion, proliferation and differentiation as well as encourage vascular invasion and ultimately new bone formation. The first clinical studies are encouraging and suggests that stem cell therapy could be a prime method for bone reconstruction.


Subject(s)
Mesoderm/cytology , Orthopedics/trends , Stem Cell Transplantation/methods , Adult , Cell Division , Humans , Stem Cells/cytology
8.
Biopolymers ; 36(4): 511-24, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7578945

ABSTRACT

In the course of a program aimed at synthesizing novel, potent NK-1 tachykinin receptor antagonists, we developed upon a bioactive model by comparing the low energy structures of a series of peptide and nonpeptide Substance P antagonists. The comparison was based on the superimposition of the aromatic rings, assuming that the rest of the molecule behaves predominantly as a template to arrange the key aromatic groups in the right spatial position. A series of 2-aminocyclohexane carboxylic acid analogues were then selected as the best templates for reproducing the postulated bioactive structure, leading to several pseudo-peptides with interesting biological activity. According to the molecular modeling, these compounds exhibit a neat parallel facing of the indolyl and naphthyl groups at about 3 A distance. Ultraviolet absorption and steady state fluorescence measurements support this conclusion, showing a linear correlation between the spectral properties and the binding affinity of these analogues. Stacking of the indole ring with naphthalene gives rise to a complex characterized by a well-defined molar extinction coefficient. Consistently, steady state and lifetime fluorescence measurements suggest that the quenching process is ascribable to ground-state interactions between the chromophores. Implications of the pi stacking propensity of aromatic groups in the biological activity of the compounds examined are briefly discussed.


Subject(s)
Amino Acids , Indoles/chemical synthesis , Neurokinin-1 Receptor Antagonists , Oligopeptides/chemical synthesis , Substance P/antagonists & inhibitors , Circular Dichroism , Indoles/chemistry , Models, Molecular , Molecular Conformation , Molecular Structure , Oligopeptides/chemistry , Protein Conformation , Structure-Activity Relationship , Substance P/analogs & derivatives , Substance P/chemical synthesis
9.
Clin Invest Med ; 18(3): 193-216, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7554586

ABSTRACT

Ketone bodies are produced in the liver, mainly from the oxidation of fatty acids, and are exported to peripheral tissues for use as an energy source. They are particularly important for the brain, which has no other substantial non-glucose-derived energy source. The 2 main ketone bodies are 3-hydroxybutyrate (3HB) and acetoacetate (AcAc). Biochemically, abnormalities of ketone body metabolism can present in 3 fashions: ketosis, hypoketotic hypoglycemia, and abnormalities of the 3HB/AcAc ratio. Normally, the presence of ketosis implies 2 things: that lipid energy metabolism has been activated and that the entire pathway of lipid degradation is intact. In rare patients, ketosis reflects an inability to utilize ketone bodies. Ketosis is normal during fasting, after prolonged exercise, and when a high-fat diet is consumed. During the neonatal period, infancy and pregnancy, times at which lipid energy metabolism is particularly active, ketosis develops readily. Pathologic causes of ketosis include diabetes, ketotic hypoglycemia of childhood, corticosteroid or growth hormone deficiency, intoxication with alcohol or salicylates, and several inborn errors of metabolism. The absence of ketosis in a patient with hypoglycemia is abnormal and suggests the diagnosis of either hyperinsulinism or an inborn error of fat energy metabolism. An abnormal elevation of the 3HB/AcAc ratio usually implies a non-oxidized state of the hepatocyte mitochondrial matrix resulting from hypoxia-ischemia or other causes. We summarize the differential diagnosis of abnormalities of ketone body metabolism, as well as pertinent recent advances in research.


Subject(s)
Hypoglycemia/diagnosis , Ketone Bodies/metabolism , Ketosis/diagnosis , Metabolism, Inborn Errors/diagnosis , 3-Hydroxybutyric Acid , Acetoacetates/metabolism , Acetone/metabolism , Biological Evolution , Brain/metabolism , Humans , Hydroxybutyrates/metabolism , Hypoglycemia/metabolism , Ketone Bodies/biosynthesis , Ketosis/metabolism , Ketosis/therapy , Menotropins/metabolism , Metabolism, Inborn Errors/metabolism , Metabolism, Inborn Errors/therapy , Mitochondria, Liver/enzymology , Mitochondria, Liver/metabolism
10.
Br J Pharmacol ; 112(1): 150-60, 1994 May.
Article in English | MEDLINE | ID: mdl-7518302

ABSTRACT

1. The aim of this study was the pharmacological characterization of tachykinin NK1 and NK2 receptors mediating contraction in the circular muscle of the guinea-pig ileum and proximal colon. The action of substance P (SP), neurokinin A (NKA) and of the synthetic agonists [Sar9]SP sulphone, [Glp6,Pro9]SP(6-11) (septide) and [beta Ala8]NKA(4-10) was investigated. The affinities of various peptide and nonpeptide antagonists for the NK1 and NK2 receptor was estimated by use of receptor selective agonists. 2. The natural agonists, SP and NKA, produced concentration-dependent contraction in both preparations. EC50 values were 100 pM and 5 nM for SP, 1.2 nM and 19 nM for NKA in the ileum and colon, respectively. The action of SP and NKA was not significantly modified by peptidase inhibitors (bestatin, captopril and thiorphan, 1 microM each). 3. Synthetic NK1 and NK2 receptor agonists produced concentration-dependent contraction of the circular muscle of the ileum and proximal colon. EC50 values were 83 pM, 36 pM and 10 nM in the ileum, 8 nM, 0.7 nM and 12 nM in the colon for [Sar9]SP sulphone, septide and [beta Ala8]NKA-(4-10), respectively. The pseudopeptide derivative of NKA(4-10), MDL 28,564 behaved as a full or near-to-full agonist in both preparations, its EC50s being 474 nM and 55 nM in the ileum and colon, respectively. 4. Nifedipine (1 microM) abolished the response to septide and [Sar9]SP sulphone in the ileum and produced a rightward shift and large depression of the response in the colon. The response to [beta Ala8]NKA(4-10) was abolished in the ileum and largely unaffected in the colon. 5. The NK1 receptor antagonists, (+/-)-CP 96,34, FK 888 and GR 82,334 competitively antagonized the response to septide and [Sar9]SP sulphone in both preparations without affecting that to [beta Ala8]NKA(4-10). In general, the NK1 receptor antagonists were significantly more potent toward septide than [Sar9]SP sulphone in both preparations. 6. The NK2 receptor antagonists, GR 94,800 and SR 48,968 selectively antagonized the response to [beta Ala8]NKA(4-10) without affecting that to [Sar9]SP sulphone or septide in the ileum and colon. SR 48,968 produced noncompetitive antagonism of the response to the NK2 receptor agonist in the ileum and competitive antagonism in the colon. 7. MEN 10,376 and the cyclic pseudopeptide MEN 10,573 antagonized in a competitive manner the response to [beta Ala8]NKA(4-10) in the ileum and colon. While MEN 10,573 was equipotent in both preparations, MEN 10,376 was significantly more potent in the colon than in the ileum. MEN 10,376was also effective against septide in both preparations, without affecting the response to [Sar9] SP sulphone. MEN 10,573 antagonized the response to [Sar9]SP sulphone and septide in both preparations,pKB values against septide being intermediate, and significantly different from, those measured against[Beta Ala 8]NKA(4-10) and [Sa9]lSP sulphone.8. These findings show that tachykinin NK1 and NK2 receptors mediate contraction of the circular muscle of the guinea-pig ileum and colon. In both preparations NK1 receptor antagonists display higher apparent affinity when tested against septide than [Sar9]SP sulphone. These findings are compatible with the proposed existence of NK1 receptor subtypes in guinea-pig, although alternative explanations (e.g.agonist binding to different epitopes of the same receptor protein) cannot be excluded at present.Furthermore, an intraspecies heterogeneity of the NK2 receptor in the circular muscle of the guinea-pig ileum and colon is suggested.


Subject(s)
Muscle, Smooth/metabolism , Receptors, Neurokinin-1/metabolism , Receptors, Neurokinin-2/metabolism , Animals , Colon/drug effects , Colon/metabolism , Guinea Pigs , Ileum/drug effects , Ileum/metabolism , In Vitro Techniques , Male , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle, Smooth/drug effects , Neurokinin A/analogs & derivatives , Neurokinin A/pharmacology , Neurokinin-1 Receptor Antagonists , Nifedipine/pharmacology , Peptide Fragments/pharmacology , Pyrrolidonecarboxylic Acid/analogs & derivatives , Receptors, Neurokinin-2/antagonists & inhibitors , Substance P/analogs & derivatives , Substance P/pharmacology , Sulfones/pharmacology
11.
Eur J Pharmacol ; 254(3): 221-7, 1994 Mar 21.
Article in English | MEDLINE | ID: mdl-7516885

ABSTRACT

We have used one peptide (FK888) and two non-peptide ((+/-)-CP-96,345 and RP 67580) antagonists, along with the preferred endogenous agonist, substance P, to compare the pharmacological (binding) profile of NK1 receptors expressed by human B lymphoblastoma (IM9) and astrocytoma (U373 MG) cells. Of the ligands tested, substance P was the most potent in both cell lines: binding affinities were 0.1 nM for IM9 cells, and 0.3 nM for U373 MG cells, respectively. The high-affinity dipeptide antagonist, FK888, bound to NK1 receptors in both cell lines with similar potencies: Ki values were 1.2 nM and 3.6 nM for IM9 cells and U373 MG cells, respectively. Of the non-peptide antagonists, as expected, (+/-)-CP-96,345 displayed higher affinity (0.4 nM in IM9 cells, and 1.2 nM in U373 MG cells) than did RP 67580 (33 nM and 223 nM in IM9 cells and U373 MG cells, respectively) in both cell lines. We conclude that the pharmacological profile of NK1 receptors is similar in the human lymphoblastoma and astrocytoma cells, i.e. if NK1 receptor subtypes exist in humans, these cell lines are likely to express a similar subtype. Because IM9 cells grow faster and are easier to maintain, this cell line may be preferable to the astrocytoma cells as a primary screen to identify NK1 receptor antagonists.


Subject(s)
Biphenyl Compounds/metabolism , Dipeptides/metabolism , Indoles/metabolism , Receptors, Neurokinin-1/analysis , Substance P/antagonists & inhibitors , Astrocytoma/metabolism , Humans , Isoindoles , Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Tumor Cells, Cultured
12.
J Med Chem ; 35(14): 2697-703, 1992 Jul 10.
Article in English | MEDLINE | ID: mdl-1635066

ABSTRACT

New carbonic anhydrase (EC 4.2.1.1) inhibitors were synthesized as potential drugs for the topical treatment of glaucoma. They were obtained by substituting the acetyl group of acetazolamide and methazolamide with bicarboxylic acids of different chain length (C4-C6). The terminal carboxyl was either kept free or esterified with alcohols of different size (C1-C12). A gamma-aminovaleric derivative was also prepared. All compounds proved active as carbonic anhydrase inhibitors in vitro, with an average IC50 of about 0.5 microM. Some proved also to be topically active in vivo in lowering the artificially elevated intraocular pressure in rabbits. The most active compound, carrying a succinic acid side chain, is the most soluble in aqueous buffers. Its duration of action is about 8 h and it is under evaluation as a topical antiglaucoma drug. It is hypothesized that the duration of action could be longer in compounds having both the same high water solubility and partition coefficient.


Subject(s)
Acetazolamide/analogs & derivatives , Acetazolamide/pharmacology , Carbonic Anhydrase Inhibitors/pharmacology , Intraocular Pressure/drug effects , Acetazolamide/administration & dosage , Administration, Topical , Animals , Carbonic Anhydrase Inhibitors/administration & dosage , Carbonic Anhydrase Inhibitors/chemistry , Glaucoma/drug therapy , Male , Methazolamide/administration & dosage , Methazolamide/analogs & derivatives , Methazolamide/pharmacology , Rabbits , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...